Moreover, accumulating evidence suggests that osteopontin (OPN) enhances IgE-mediated degranulation of mast cells through binding to CD44 [38] and that CD44 can activate the PI3K/Akt and MAPK/ERK pathways in leukemia cells [39]. This evidence concerns the gene IGHE and leukemia.